Reviva Pharmaceuticals (RVPHW) has a market capitalization of $84.1M, based on 1.29B shares at a price of $0.07 (down 2% yesterday).
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
October 2025 | $0.07 | 673,758 | 1,292,380,271 | $84,133,955.64 |
September 2025 | $0.08 | 1,226,373 | 49,847,900 | $3,987,832.00 |
August 2025 | $0.06 | 3,263,732 | 49,847,900 | $2,990,874.00 |
July 2025 | $0.03 | 1,721,829 | 49,847,900 | $1,520,360.95 |
June 2025 | $0.03 | 808,814 | 49,847,900 | $1,610,087.17 |
May 2025 | $0.07 | 1,183,681 | 49,847,900 | $3,474,398.63 |
April 2025 | $0.06 | 2,113,012 | 49,847,900 | $3,040,721.90 |
March 2025 | $0.05 | 1,211,359 | 48,644,300 | $2,670,572.07 |
February 2025 | $0.13 | 345,897 | 48,644,300 | $6,085,401.93 |
January 2025 | $0.20 | 683,363 | 48,644,300 | $9,631,571.40 |
December 2024 | $0.16 | 1,399,074 | 46,579,200 | $7,657,620.48 |
November 2024 | $0.22 | 369,218 | 46,579,200 | $10,014,528.00 |
October 2024 | $0.10 | 122,126 | 46,579,200 | $4,657,920.00 |
September 2024 | $0.14 | 362,197 | 33,804,700 | $4,563,634.50 |
August 2024 | $0.12 | 486,610 | 33,804,700 | $4,056,564.00 |
July 2024 | $0.14 | 433,466 | 33,804,700 | $4,732,658.00 |
June 2024 | $0.27 | 107,849 | 30,555,000 | $8,249,850.00 |
May 2024 | $0.30 | 389,118 | 30,555,000 | $9,105,390.00 |
April 2024 | $0.50 | 327,610 | 30,555,000 | $15,243,889.50 |
March 2024 | $0.63 | 476,396 | 29,887,300 | $18,846,931.38 |
February 2024 | $0.84 | 258,088 | 29,887,300 | $25,027,625.02 |
January 2024 | $1.00 | 338,575 | 29,887,300 | $29,887,300.00 |
December 2023 | $1.43 | 340,440 | 27,918,600 | $39,923,598.00 |
November 2023 | $0.80 | 657,613 | 27,918,600 | $22,334,880.00 |
October 2023 | $1.20 | 678,875 | 27,918,600 | $33,502,320.00 |
